These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 481099
1. Examination of des-tyrosine1-gamma-endorphin activity at oH-spiroperidol binding sites in rat brain. Pedigo NW, Ling NC, Reisine TD, Yamamura HI. Life Sci; 1979 Apr 30; 24(18):1645-9. PubMed ID: 481099 [No Abstract] [Full Text] [Related]
2. Lack of effect of des-tyrosine1-gamma-endorphin on in vivo [3H]spiperone binding. Lahti RA, Gay DD. Eur J Pharmacol; 1982 May 07; 80(1):127-9. PubMed ID: 6124435 [No Abstract] [Full Text] [Related]
3. Inhibition of in vivo 3H-spiperone binding by the proposed antipsychotic Des-Tyr1-gamma-endorphin. Pedigo NW, Schallert T, Overstreet DH, Ling NC, Ragan P, Reisine TD, Yamamura HI. Eur J Pharmacol; 1979 Dec 20; 60(4):359-64. PubMed ID: 43261 [Abstract] [Full Text] [Related]
4. Effect of morphine, beta-endorphin and leu-enkephalin on 3H-spiroperidol binding to bovine pituitary membranes. Meltzer HY, So R. Life Sci; 1979 Aug 06; 25(6):531-5. PubMed ID: 491848 [No Abstract] [Full Text] [Related]
5. In vivo interaction of gamma-type endorphins with dopaminergic ligands in rat brain. Codd EE, Scholtens H, Wolterink G, Verhoef JC, Van Ree JM, Witter A. Eur J Pharmacol; 1983 Apr 08; 88(4):365-70. PubMed ID: 6861877 [Abstract] [Full Text] [Related]
6. 3H-Spiroperidol binding to two receptor sites in both the corpus striatum and frontal cortex of rat brain. Pedigo NW, Reisine TD, Fields JZ, Yamamura HI. Eur J Pharmacol; 1978 Aug 15; 50(4):451-3. PubMed ID: 699968 [No Abstract] [Full Text] [Related]
7. Inhibition of 3H-spiroperidol binding by an endogenous material from brain. Lahti RA, Gay DD, Barsuhn C. Eur J Pharmacol; 1978 Dec 15; 53(1):117-8. PubMed ID: 738355 [No Abstract] [Full Text] [Related]
8. Decreased in vivo [3H]spiroperidol binding in rat brain after repeated methamphetamine administration. Kaneno S, Shimazono Y. Eur J Pharmacol; 1981 Jun 10; 72(1):101-5. PubMed ID: 7196335 [No Abstract] [Full Text] [Related]
9. Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites. Fuxe K, Agnati LF, Benfenati F, Cimmino M, Algeri S, Hökfelt T, Mutt V. Acta Physiol Scand; 1981 Dec 10; 113(4):567-9. PubMed ID: 6291324 [No Abstract] [Full Text] [Related]
10. Effects of chronic haloperidol, thioridazine and zotepine treatment on apomorphine elicited stereotypic behavior and 3H-spiroperidol binding sites in the striatum of the rat. Lai HC, Carino MA, Horita A. Proc West Pharmacol Soc; 1981 Dec 10; 24():5-6. PubMed ID: 6114496 [No Abstract] [Full Text] [Related]
11. [An experimental study on the reverse tolerance phenomenon induced by chronic methamphetamine administration in rats: the changes in [3H]-spiperone binding sites in discrete brain areas (author's transl)]. Akiyama K. Seishin Shinkeigaku Zasshi; 1982 Dec 10; 84(4):227-42. PubMed ID: 7111517 [No Abstract] [Full Text] [Related]
12. Effect of chronic phencyclidine or d-amphetamine treatment on [3H]spiroperidol binding in rat caudate-putamen and nucleus accumbens. Daiguji M, Meltzer HY. Eur J Pharmacol; 1982 Dec 03; 85(3-4):339-42. PubMed ID: 7151875 [Abstract] [Full Text] [Related]
13. Two binding sites for 3H-spiroperidol on rat striatal membranes. Briley M, Langer SZ. Eur J Pharmacol; 1978 Aug 01; 50(3):283-4. PubMed ID: 28956 [No Abstract] [Full Text] [Related]
14. Chronic lithium reduces [3H]spiroperidol binding in rat striatum. Rosenblatt JE, Pert A, Layton B, Bunney WE. Eur J Pharmacol; 1980 Oct 17; 67(2-3):321-2. PubMed ID: 7461036 [No Abstract] [Full Text] [Related]
15. Solubilization of 3H-spiperone binding sites from rat brain. Gorissen H, Laduron PM. Life Sci; 1978 Aug 14; 23(6):575-9. PubMed ID: 692282 [No Abstract] [Full Text] [Related]
16. Agonist interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings]. Howlett DR, Morris H, Nahorski SR. Br J Pharmacol; 1979 May 14; 66(1):136P. PubMed ID: 454928 [No Abstract] [Full Text] [Related]
17. Does [3H]spiroperidol label a 5-HT receptor in the frontal cortex of the rat? Middlemiss DN, Carroll JA, Fisher RW, Mounsey IJ. Eur J Pharmacol; 1980 Aug 29; 66(2-3):253-4. PubMed ID: 7439272 [No Abstract] [Full Text] [Related]
18. Effect of cyclo(leucyl-glycine) on [3H]spiroperidol binding in the corpus striatum and hypothalamus of spontaneously hypertensive rats. Bhargava HN. Eur J Pharmacol; 1984 Apr 13; 100(1):109-12. PubMed ID: 6723774 [Abstract] [Full Text] [Related]
19. Chronic administration of D-amphetamine increases [3H]spiroperidol binding in cat brain. Trulson ME, Crisp T. Eur J Pharmacol; 1985 Nov 05; 117(2):267-70. PubMed ID: 4076345 [Abstract] [Full Text] [Related]
20. [Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]. Vasar EE, Nurk AM, Maĭmets MO, Allikmets LKh. Biull Eksp Biol Med; 1985 Jan 05; 99(1):72-4. PubMed ID: 2857100 [Abstract] [Full Text] [Related] Page: [Next] [New Search]